... prediction of survival outcome and benefit from molecular targeted therapy. Den vetenskapliga artikeln ovan är utsedd till ... Molecular stratification of metastatic melanoma using gene expression profiling - ...
The molecular biology of endometrial cancers and the implications for pathogenesis, classification, and targeted therapies. ...
13.50-14.20 Novel molecular tools to investigate signaling pathways Associate Prof Ola Söderberg 14.25-14.55 Targeted re- ... 15.20-15.50 Targeted therapeutics of CLL - spring has arrived! Prof Anders Österborg. 15.55-16.25 Targeted therapy in lymphoma ... Mini-symposium: Aberrant signaling pathways and targeted therapies in lymphoid malignancies * Invitation to Nordic CML school ... Mini-symposium: Aberrant signaling pathways and targeted therapies in lymphoid malignancies. 2013-12-12 12:30:00 ...
A molecular revolution in uveal melanoma: implications for patient care and targeted therapy. Ophthalmology. 2014;121(6):1281-8 ... Expert review of anticancer therapy. 2006;6(4):493-506.. 4. Char DH. Ocular melanoma. The Surgical clinics of North America. ... Gene expression profiling in uveal melanoma reveals two molecular classes and predicts metastatic death. Cancer research. 2004; ...
Salvi et al: Efficacy of B-cell targeted therapy with rituximab in patients with active moderate to severe Graves orbitopathy ... Wang Y, Smith TJ, Current concepts in the molecular pathogenesis of thyroid-associated ophthalmopathy. Inves Ophthalmol Vis Sci ...
Discordancy in BRAF mutations among primary and metastatic melanoma lesions: clinical implications for targeted therapy. Modern ... The Journal of molecular diagnostics : JMD. 2016;18(1):75-83.. 23. Malignant Malignant Melanoma of Skin. In: TNM Classification ...
... a potential target for therapy of remodelling after myocardial infarction? ^ First "hybrid" ligands of vanilloid TRPV1 and ... Molecular biology of cannabinoid receptors ^ Structure and function of a custom anticancer peptide, CB1a ^ Identification and ... Cannabinoid receptors as a target for therapy of ovarian cancer ^ Marijuana Use and the Risk of Lung and ... Molecular characterization of a peripheral receptor for cannabinoids ^ [a b] Agonist-directed trafficking of response by ...
Karolinska Institutet, KID (STAT3 as a target for anti-cancer therapy). Gruppmedlemmar. Katja Pokrovskaja Tamm, PI, PhD, docent ... Barncancerfonden (Molecular mechanisms underlying pediatric leukemia development and treatment). *Stiftelsen för Strategisk ... Cancerfonden (Mechanisms of action of anti-cancer drugs and therapy resistance, STAT3 in cancer and therapy resistance) ... Forskning, Industridoktorand (Autophagy in anti-cancer therapy). *Konung Gustaf V:s Jubileumsfond (Drug development to overcome ...
Oswald, F., et al. p300 acts as a transcriptional coactivator for mammalian Notch-1. Molecular and Cellular Biology. 21, (22), ... Xiu, M. X., Liu, Y. M. The role of oncogenic Notch2 signaling in cancer: a novel therapeutic target. American Journal of Cancer ... Allenspach, E. J., Maillard, I., Aster, J. C., Pear, W. S. Notch signaling in cancer. Cancer Biololgy & Therapy. 1, (5), 466- ... Jia, D., Huang, Y. C., Deng, W. M. Analysis of Cell Cycle Switches in Drosophila Oogenesis. Methods in Molecular Biology. 1328 ...
Gaining insight into these mechanisms could lead to targeted therapies for illnesses such as pain disorders. ... My research consists in identifying the molecular mechanisms that control neurogenesis and specification during development and ... Post-doctoral fellow, Department of Medical Biochemistry and Biophysics, Molecular Neurobiology, Karolinska Institutet, Sweden ... Post-doctoral fellow, Department of Cell and Molecular biology, Karolinska Institutet, Sweden ...
8. Guy ES, Mallampalli A. Managing TB in the 21st century: existing and novel drug therapies. Ther Adv Respir Dis. 2008;2:401-8 ... 7. Blöndal K. Barriers to reaching the targets for tuberculosis control: multidrug-resistant tuberculosis. Bull World Health ... but transmission in Sweden was confirmed by molecular typing in at least 1 case. Despite the serious prognosis a majority of ... Direktövervakad behandling (DOT, direct observed therapy) tillämpades inte konsekvent - särskilt inte under den tidiga delen av ...
Palmer, G. M., et al. In vivo optical molecular imaging and analysis in mice using dorsal window chamber models applied to ... Straetemans, T., et al. T-cell receptor gene therapy in human melanoma-bearing immune-deficient mice: human but not mouse T ... Schiffelers, R. M., et al. Ligand-targeted liposomes directed against pathological vasculature. J Liposome Res. 12, 129-135 ( ... Massoud, T. F., Gambhir, S. S. Molecular imaging in living subjects: seeing fundamental biological processes in a new light. ...
Genetic causes and molecular mechanisms underlying rare metabolic bone diseases on June 14th, 2019. Main Supervisor is Outi ... understanding the pathogenesis of these diseases could eventually lead to the development of targeted therapies. ... Alice Costantini from the research group Clinical Genetics will defend her thesis Genetic causes and molecular mechanisms ...
Congenital myasthenic syndromes: multiple molecular targets at the neuromuscular junction. Ann NY Acad Sci 2003; 998: 138-160. ... Ephedrine therapy in eight patients with congenital myasthenic syndrome due to DOK7 mutations. Neuromuscul Disord 2009; 12: 828 ... Quinidine sulfate therapy for the slow-channel congenital myasthenic syndrome. Ann Neurol 1998; 43: 480-484. ... Weatherall Institute of Molecular Medicine, The John Radcliffe Hospital, Headington, Oxford, Storbritannien (professor D Beeson ...
Molecular and Cellular Endocrinology, Artikel i vetenskaplig tidskrift 2020 Artikel i vetenskaplig tidskrift ... Importance of thorough tissue and cellular level characterization of targeted drugs in the evaluation of pharmacodynamic ... Diabetes Therapy, Artikel i vetenskaplig tidskrift 2019 Artikel i vetenskaplig tidskrift Direkt till fulltext. på webbsida ...
Are the actions of thrombin on platelets an important target for antithrombotic therapy? Hjemdahl, Paul - Is thrombin a key ... Exam Molecular Bioinformatics X3 (1MB330) - 1 March, Page 1 of 6. Skriv svar på varje uppgift på separata blad. Lycka till!! ... Exam Molecular Bioinformatics X (MB) - March, - Page of Skriv svar på varje uppgift på separata blad. Lycka till!! Write the ... 10 Molecular Medicine 2002, XXVIII Nordic Congress in Clinical Chemistry and XXXV Conference on Coagulation, Reykjavik August ...
... and the application of targeted therapy in the treatment of hematologic disorders. New to this Edition: Full-color presentation ... The book begins with the evaluation of the patient and progresses to the molecular and cellular underpinnings of normal and ... and the application of targeted therapy in the treatment of hematologic disorders. New to this Edition: Full-color presentation ... The book begins with the evaluation of the patient and progresses to the molecular and cellular underpinnings of normal and ...
Radionuclide molecular imaging, Theranostics, Peptide receptor radionuclide therapy (PRRT). Nationell ämneskategori ... This expression pattern indicates that GRPR could be a promising target for imaging and treatment of oligometa-static prostate ... Anti-HER2 therapy additionally improved survival.. Ort, förlag, år, upplaga, sidor. 2019. Vol. 145, nr 12, s. 3347-3358 ... radionuclide therapy, GRPR, HER2, prostate cancer, lutetium-177 Nationell ämneskategori Cancer och onkologi Identifikatorer. ...
Explorative and targeted neuroproteomics in Alzheimers disease. Ann Brinkmalm-Westman, Erik Portelius, Annika Öhrfelt, Gunnar ... Alzheimers Research & Therapy, Artikel i vetenskaplig tidskrift 2015 Artikel i vetenskaplig tidskrift ... Molecular Psychiatry, Artikel i vetenskaplig tidskrift 2014 Artikel i vetenskaplig tidskrift Direkt till fulltext. på webbsida ... Explorative and targeted neuroproteomics in Alzheimers disease. Ann Brinkmalm-Westman, Erik Portelius, Annika Öhrfelt, Gunnar ...
... both of which play critical roles in cancer biology and the response to cancer therapy. By using a biochemical, molecular, and ... cell biology-focused approach, we aim to identify potential biomarkers and therapeutic targets involved in these pathways that ... Targeting SAMHD1 With the Vpx Protein to Improve Cytarabine Therapy for Hematological Malignancies. 2017. Nat Med. PMID: ...
CLCN-1 mutations in myotonia congenita patients: insights into molecular gating mechanisms and genotype-phenotype correlation. ... Sodium channel slow inactivation as a therapeutic target for myotonia congenita. Ann Neurol 2015; 77: 320-332. ... Muscle channelopathies: recent advances in genetics, pathophysiology and therapy. Curr Opin Neurol 2014; 27: 583-590. ...
Targeted Therapy for Low Back Pain in Elderly Degenerative Lumbar Scoliosis K. Yamada, T. Nakamae, T. Shimbo, T. Kanazawa, T. ... The Intervertebral Disc: Molecular and Structural Studies of the Disc in Health and Disease, Springer, Kapitel i bok 2014 ...
Projekttitel: "Molecular and cellular therapies against COVID-19 using angiotensin-converting enzyme 2 (ACE2)" ... Projekttitel: Targeted cancer immunotherapy by extracellular vesicles. CIMED projektbidrag 2021-2023 Senior. Ali Mirazimi ...
Therapeutic peptides are a fast growing industry and many molecular therapies are being explored in the best companies and ... peptides and specific growth factors that are delivered to the target cell receptors . Through these signal transduction ...
Targeted alpha therapy with astatine-211-labeled anti-PSCA A11 minibody shows antitumor efficacy in prostate cancer xenografts ... Molecular and cellular endocrinology, Artikel i vetenskaplig tidskrift 2016 Artikel i vetenskaplig tidskrift ... Targeted alpha therapy with astatine-211-labeled anti-PSCA A11 minibody shows antitumor efficacy in prostate cancer xenografts ... Molecular and cellular endocrinology, Artikel i vetenskaplig tidskrift 2016 Artikel i vetenskaplig tidskrift ...